MARC details
000 -LEADER |
fixed length control field |
03308cam a22004815i 4500 |
001 - CONTROL NUMBER |
control field |
21939011 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240305192324.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
fixed length control field |
m |o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
160909s2016 gw |||| o |||| 0|eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2019769991 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783319406978 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-319-40697-8 |
Source of number or code |
doi |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(DE-He213)978-3-319-40697-8 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
pn |
-- |
rda |
Transcribing agency |
DLC |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED033000 |
Source |
bisacsh |
|
Subject category code |
MJT |
Source |
bicssc |
|
Subject category code |
MKC |
Source |
thema |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
618.2 |
Edition information |
23 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Källén, Bengt, |
Relator term |
author. |
9 (RLIN) |
30941 |
245 10 - TITLE STATEMENT |
Title |
Drugs During Pregnancy : |
Remainder of title |
Methodological Aspects / |
Statement of responsibility, etc. |
by Bengt Källén. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2016. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2016. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource (XI, 111 pages 26 illustrations in color.) |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Introduction -- The alert clinician -- Animal experiments and adverse drug reaction reports -- Some epidemiological principles -- Pregnancy outcomes with the exception of congenital malformations -- Congenital malformations -- Identification of maternal use of drugs -- The problem of confounding -- Statistics -- Lumping or splitting? Paternal use of drugs -- Timing of drug use and effects on the embryo or fetus -- Repeated studies and meta-analysis -- Pharmacovigilance -- Information on the risk with drug use during pregnancy -- Concluding remarks. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This book addresses methodological aspects of epidemiological studies on maternal drug use in pregnancy. Discussing the existing sources of error and how they can produce incorrect conclusions, it examines various epidemiological techniques and assesses their strengths and weaknesses. These refer both to the identification of outcomes (with special emphasis on congenital malformations) and to the types of exposure (drug use). Further, the book discusses the problem of confounding and how to handle it, and provides a simple introduction to statistics. Special situations, e.g. different types of parental exposure, are examined. Lastly, the book discusses pharmacovigilance and the information problem, concluding with a short list of aspects to consider when one wants to evaluate a published paper in the field. Though the book is primarily intended for pharmacologists, gynecologists and obstetricians, it will benefit all doctors working in perinatal care. |
588 ## - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Description based on publisher-supplied MARC data. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
9 (RLIN) |
1175 |
|
9 (RLIN) |
6991 |
|
Authority record control number or standard number |
https://scigraph.springernature.com/ontologies/product-market-codes/H26014 |
9 (RLIN) |
4103 |
|
Authority record control number or standard number |
https://scigraph.springernature.com/ontologies/product-market-codes/H69000 |
9 (RLIN) |
6991 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Print version: |
Title |
Drugs during pregnancy : methodological aspects |
International Standard Book Number |
9783319406961 |
Record control number |
(DLC) 2016952092 |
|
Relationship information |
Printed edition: |
International Standard Book Number |
9783319406961 |
|
Relationship information |
Printed edition: |
International Standard Book Number |
9783319406985 |
|
Relationship information |
Printed edition: |
International Standard Book Number |
9783319821580 |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
0 |
b |
ibc |
c |
origres |
d |
u |
e |
ncip |
f |
20 |
g |
y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
ddc |
Koha item type |
E-BOOKS |